Correction to: Nature Communications 10.1038/s41467-020-20677-0, published online 18 January 2021.
The original version of the Peer Review File associated with this Article was updated shortly after publication to redact unpublished data.
. 2021 Feb 8;12:989. doi: 10.1038/s41467-021-21406-x
Publisher Correction: Loss of POMC-mediated antinociception contributes to painful diabetic neuropathy
Divija Deshpande
1,2,3, Nitin Agarwal
2,#, Thomas Fleming
1,4,#, Claire Gaveriaux-Ruff
5,6,7,8,9, Christoph S N Klose
3, Anke Tappe-Theodor
2, Rohini Kuner
2, Peter Nawroth
1,4,10,✉
Divija Deshpande
1Department of Medicine I and Clinical Chemistry, University Hospital of Heidelberg, INF 410, Heidelberg, Germany
2Institute of Pharmacology, Heidelberg University, INF 366, Heidelberg, 69120 Germany
3Department of Microbiology, Infectious Diseases and Immunology, Charité-Universitätsmedizin Berlin, Hindenburgdamm 30, 12203 Berlin, Germany
Find articles by Divija Deshpande
Nitin Agarwal
2Institute of Pharmacology, Heidelberg University, INF 366, Heidelberg, 69120 Germany
Find articles by Nitin Agarwal
Thomas Fleming
1Department of Medicine I and Clinical Chemistry, University Hospital of Heidelberg, INF 410, Heidelberg, Germany
4German Center for Diabetes Research (DZD), Neuherberg, Germany
Find articles by Thomas Fleming
Claire Gaveriaux-Ruff
5Institut de Génétique et de Biologie Moléculaire et Cellulaire, Department of Translational Medicine and Neurogenetics, Illkirch, France
6Université de Strasbourg, Illkirch, France
7Centre National de la Recherche Scientifique, UMR7104 Illkirch, France
8Institut National de la Santé et de la Recherche Médicale, U1258 Illkirch, France
9Ecole Supérieure de Biotechnologie de Strasbourg, Illkirch, France
Find articles by Claire Gaveriaux-Ruff
Christoph S N Klose
3Department of Microbiology, Infectious Diseases and Immunology, Charité-Universitätsmedizin Berlin, Hindenburgdamm 30, 12203 Berlin, Germany
Find articles by Christoph S N Klose
Anke Tappe-Theodor
2Institute of Pharmacology, Heidelberg University, INF 366, Heidelberg, 69120 Germany
Find articles by Anke Tappe-Theodor
Rohini Kuner
2Institute of Pharmacology, Heidelberg University, INF 366, Heidelberg, 69120 Germany
Find articles by Rohini Kuner
Peter Nawroth
1Department of Medicine I and Clinical Chemistry, University Hospital of Heidelberg, INF 410, Heidelberg, Germany
4German Center for Diabetes Research (DZD), Neuherberg, Germany
10Joint Heidelberg-IDC Translational Diabetes Program, Helmholtz Zentrum, 85764 Neuherberg, Germany
Find articles by Peter Nawroth
1Department of Medicine I and Clinical Chemistry, University Hospital of Heidelberg, INF 410, Heidelberg, Germany
2Institute of Pharmacology, Heidelberg University, INF 366, Heidelberg, 69120 Germany
3Department of Microbiology, Infectious Diseases and Immunology, Charité-Universitätsmedizin Berlin, Hindenburgdamm 30, 12203 Berlin, Germany
4German Center for Diabetes Research (DZD), Neuherberg, Germany
5Institut de Génétique et de Biologie Moléculaire et Cellulaire, Department of Translational Medicine and Neurogenetics, Illkirch, France
6Université de Strasbourg, Illkirch, France
7Centre National de la Recherche Scientifique, UMR7104 Illkirch, France
8Institut National de la Santé et de la Recherche Médicale, U1258 Illkirch, France
9Ecole Supérieure de Biotechnologie de Strasbourg, Illkirch, France
10Joint Heidelberg-IDC Translational Diabetes Program, Helmholtz Zentrum, 85764 Neuherberg, Germany
✉
Corresponding author.
#
Contributed equally.
Collection date 2021.
Subject terms: Cell biology, Molecular biology, Neuroscience, Diseases, Endocrinology
© The Author(s) 2021
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
PMCID: PMC7870942 PMID: 33558501
This corrects the article "Loss of POMC-mediated antinociception contributes to painful diabetic neuropathy", 426.